| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018700 | Digestive and Liver Disease | 2018 | 4 Pages |
Abstract
In ASUC, SEL were not associated with more loss of IFX in the stool or lower plasmatic levels. Early IFX pharmacokinetics in this setting does not seem related to endoscopic severity.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Florian Poullenot, Dorothée Nivet, Stéphane Paul, Pauline Riviere, Xavier Roblin, David Laharie,